Wockhardt Q3 Profit Jumps 3x to Rs 61 Cr

1 Minute Read Listen to Article
Share:    

Feb 10, 2026 17:38

x
Wockhardt's Q3 profit after tax surged threefold to Rs 61 crore. Revenue rose to Rs 888 crore. Upcoming insulin analogs launch is a key opportunity.
New Delhi, Feb 10 (PTI) Drug firm Wockhardt on Tuesday said its

consolidated profit after tax surged over threefold to Rs 61 crore in the third quarter ended December 31, 2025.

The Mumbai-based firm reported a profit after tax of Rs 20 crore for the October-December period of last fiscal.

Total revenue increased to Rs 888 crore in the third quarter from Rs 725 crore a year ago, Wockhardt Ltd said in a statement.

The company's strength lies in its robust and end-to-end well integrated biotech infrastructure, it noted.



"Looking ahead, the upcoming launch of insulin analogs over the next few

quarters represents a significant business opportunity, further strengthening our

commitment to meeting global diabetes healthcare needs and advancing our leadership in diabetes care," the company stated.

Wockhardt shares on Tuesday ended 1.09 per cent up at Rs 1,428.70 apiece on BSE. PTI MSS

ANU

ANU
Share:    

TODAY'S MOST TRADED COMPANIES

  • Company Name
  • Price
  • Volume

See More >

Moneywiz Live!

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback